{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:06:37Z","timestamp":1778285197887,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10157-018-1537-7","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T07:28:18Z","timestamp":1517902098000},"page":"938-946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ensuring safe drug administration to pediatric patients with renal dysfunction: a multicenter study"],"prefix":"10.1007","volume":"22","author":[{"given":"Ryoko","family":"Harada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Shinozuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoaki","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riku","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hataya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae","family":"Omori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"1537_CR1","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/ki.2009.353","volume":"76","author":"BL Hug","year":"2009","unstructured":"Hug BL, Witkowski DJ, Sox CM, Keohane CA, Segar DL, Yoon C, Matheny ME, Bates DW. Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney. Kidney Int. 2009;76:1192\u20138.","journal-title":"Kidney Int"},{"key":"1537_CR2","doi-asserted-by":"publisher","first-page":"e001868","DOI":"10.1136\/bmjopen-2012-001868","volume":"19","author":"DC Silva","year":"2013","unstructured":"Silva DC, Araujo OR, Arduini RG, Alonso CF, Shibata AR, Troster EJ. Adverse drug events in a paediatric intensive care unit: a prospective cohort. BMJ Open. 2013;19:e001868.","journal-title":"BMJ Open"},{"key":"1537_CR3","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.285.16.2114","volume":"285","author":"R Kaushal","year":"2001","unstructured":"Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, Goldmann DA. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285:2114\u201320.","journal-title":"JAMA"},{"key":"1537_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2215\/CJN.02050309","volume":"4","author":"MA Perazella","year":"2009","unstructured":"Perazella MA. Renal vulnerability to drug toxicity. Clin J Am Soc Nephrol. 2009;4:1275\u201383.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1537_CR5","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1128\/AAC.01430-08","volume":"53","author":"JF Oliveira","year":"2009","unstructured":"Oliveira JF, Silva CA, Barbieri CD, Oliveira GM, Zanetta DM, Burdmann EA. Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units. Antimicrob Agents Chemother. 2009;53:2887\u201391.","journal-title":"Antimicrob Agents Chemother"},{"key":"1537_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ndt\/gfq375","volume":"26","author":"M Zappitellu","year":"2011","unstructured":"Zappitellu M, Moffett BS, Hyder A, Goldstein SL. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transpl. 2011;26:144\u201350.","journal-title":"Nephrol Dial Transpl"},{"key":"1537_CR7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.18553\/jmcp.2012.18.3.234","volume":"18","author":"M Kelkar","year":"2012","unstructured":"Kelkar M, Cleves MA, Foster HR, Hogan WR, James LP, Martin BC. Acute and chronic acetaminophen use and renal disease: a case-control study using pharmacy and medical claims. J Manag Care Pharm. 2012;18:234\u201346.","journal-title":"J Manag Care Pharm"},{"key":"1537_CR8","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1007\/s11739-012-0803-z","volume":"7","author":"G Marenzi","year":"2012","unstructured":"Marenzi G, Cabiati A, Milazzo V, Rubino M. Contrast-induced nephropathy. Intern Emerg Med. 2012;7:S181\u20133.","journal-title":"Intern Emerg Med"},{"key":"1537_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s10157-011-0452-y","volume":"15","author":"O Uemura","year":"2011","unstructured":"Uemura O, Honda M, Matsuyama T, Ishikura K, Hataya H, Yata N, Nagai T, Ikezumi Y, Fujita N, Ito S, Iijima K, Kitagawa T. Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol. 2011;15:694\u20139.","journal-title":"Clin Exp Nephrol"},{"key":"1537_CR10","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1093\/ndt\/gfs611","volume":"28","author":"K Ishikura","year":"2013","unstructured":"Ishikura K, Uemura O, Ito S, Wada N, Hattori M, Ohashi Y, Hamasaki Y, Tanaka R, Nakanishi K, Kaneko T, Honda M, Pediatric CKD. Study Group, Japan Committee of Measures for Pediatric CKD of the Japanese Society of Pediatric Nephrology. Pre-dialysis chronic kidney disease in children: results of a nationwide survey in Japan. Nephrol Dial Transpl. 2013;28:2345\u201355.","journal-title":"Nephrol Dial Transpl"},{"key":"1537_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s10157-013-0856-y","volume":"18","author":"O Uemura","year":"2014","unstructured":"Uemura O, Nagai T, Ishikura K, Ito S, Hataya H, Gotoh Y, Fujita N, Akioka Y, Kaneko T, Honda M. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18:626\u201333.","journal-title":"Clin Exp Nephrol"},{"key":"1537_CR12","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.1016\/S0002-9343(99)00113-8","volume":"106","author":"A Whelton","year":"1999","unstructured":"Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med. 1999;106:13S\u201324S.","journal-title":"Am J Med"},{"key":"1537_CR13","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/ki.1988.83","volume":"33","author":"HD Humes","year":"1988","unstructured":"Humes HD. Aminoglycoside nephrotoxicity. Kidney Int. 1988;33:900\u201311.","journal-title":"Kidney Int"},{"key":"1537_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0002-9343(99)00041-8","volume":"106","author":"MA Perazella","year":"1999","unstructured":"Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999;106:459\u201365.","journal-title":"Am J Med"},{"key":"1537_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1056\/NEJM198901193200303","volume":"320","author":"PS Parfrey","year":"1989","unstructured":"Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Eng J Med. 1989;320:143\u20139.","journal-title":"N Eng J Med"},{"key":"1537_CR16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3565(25)32105-1","volume":"213","author":"DC Dobyan","year":"1980","unstructured":"Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther. 1980;213:551\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"1537_CR17","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1046\/j.1523-1755.2001.00948.x","volume":"60","author":"DW Bates","year":"2001","unstructured":"Bates DW, Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, Platt R. Correlates of acute renal failure in patients receiving parenteral amphotericin B. Kidney Int. 2001;60:1452\u20139.","journal-title":"Kidney Int"},{"key":"1537_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archinte.160.5.685","volume":"160","author":"GL Bakris","year":"2000","unstructured":"Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med. 2000;160:685\u201393.","journal-title":"Arch Intern Med"},{"key":"1537_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0002-9343(01)00784-7","volume":"111","author":"HY Lee","year":"2001","unstructured":"Lee HY, Kim CH. Acute oliguric renal failure associated with angiotensin II receptor antagonists. Am J Med. 2001;111:162\u20133.","journal-title":"Am J Med"},{"key":"1537_CR20","doi-asserted-by":"publisher","first-page":"e0158677","DOI":"10.1371\/journal.pone.0158677","volume":"11","author":"A Saleem","year":"2016","unstructured":"Saleem A, Masood I. Pattern and predictors of medication dosing errors in chronic kidney disease patients in Pakistan: a single center retrospective analysis. PLoS One. 2016;11:e0158677.","journal-title":"PLoS One"},{"key":"1537_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00000441-200507000-00002","volume":"330","author":"AM Redmond","year":"2005","unstructured":"Redmond AM, Pentapaty N, Weibel J, Nolan SF, Hudson JQ, Self T. Use of famotidine in adult patients with end-stage renal disease: assessment of dosing and mental status changes. Am J Med Sci. 2005;330:8\u201310.","journal-title":"Am J Med Sci"},{"key":"1537_CR22","first-page":"647","volume":"107","author":"B Hartmann","year":"2010","unstructured":"Hartmann B, Czock D, Keller F. Drug therapy in patients with chronic renal failure. Dtsch Arztebl Int. 2010;107:647\u201355.","journal-title":"Dtsch Arztebl Int"},{"key":"1537_CR23","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00467-005-1922-9","volume":"20","author":"M Daschner","year":"2005","unstructured":"Daschner M. Drug dosage in children with reduced renal function. Pediatr Nephrol. 2005;20:1675\u201386.","journal-title":"Pediatr Nephrol"},{"key":"1537_CR24","unstructured":"National Kidney Foundation. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int suppl 3. http:\/\/www.kdigo.org\/clinical_practice_guidelines\/pdf\/CKD\/KDIGO_2012_CKD_GL.pdf ."},{"key":"1537_CR25","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/ki.2010.475","volume":"81","author":"MA Perazella","year":"2012","unstructured":"Perazella MA. Drug use and nephrotoxicity in the intensive care unit. Kidney Int. 2012;81:1172\u20138.","journal-title":"Kidney Int"},{"key":"1537_CR26","doi-asserted-by":"publisher","first-page":"e1575","DOI":"10.1542\/peds.2013-3060","volume":"133","author":"JA Feinstein","year":"2014","unstructured":"Feinstein JA, Feudther C, Kempe A. Adverse drug event-related emergency department visits associated with complex chronic conditions. Pediatrics. 2014;133:e1575\u201385.","journal-title":"Pediatrics"},{"key":"1537_CR27","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1542\/peds.2013-0794","volume":"132","author":"SL Goldstein","year":"2013","unstructured":"Goldstein SL, Kirkendall E, Nguyen H, Schaffzin JK, Bucuvalas J, Bracke T, Seid M, Ashby M, Foertmeyer N, Brunner L, Lesko A, Barclay C, Lannon C, Muething S. Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics. 2013;132:e756\u201367.","journal-title":"Pediatrics"},{"key":"1537_CR28","doi-asserted-by":"publisher","first-page":"856","DOI":"10.2215\/CJN.08110910","volume":"6","author":"BS Moffet","year":"2011","unstructured":"Moffet BS, Goldstein SL. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol. 2011;6:856\u201363.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1537_CR29","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jpeds.2014.04.058","volume":"165","author":"S Menon","year":"2014","unstructured":"Menon S, Kirkendall ES, Nguyen H, Goldstein SL. Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months. J Pediatr. 2014;165:522\u20137.","journal-title":"J Pediatr"},{"key":"1537_CR30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2215\/CJN.12101112","volume":"8","author":"SL Goldstein","year":"2013","unstructured":"Goldstein SL, Jaber BL, Faubel S, Chawla LS. Acute Kidney Injury Advisory Group of American Society of Nephrology. AKI transition of care: a potential opportunity to detect and prevent CKD. Clin J Am Soc Nephrol. 2013;8:476\u201383.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1537_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00467-010-1653-4","volume":"26","author":"SL Goldstein","year":"2011","unstructured":"Goldstein SL, Devarajan P. Acute kidney injury in childhood: should we be worried about progression to CKD? Pediatr Nephrol. 2011;26:509\u201322.","journal-title":"Pediatr Nephrol"},{"key":"1537_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/sj.ki.5000032","volume":"69","author":"DJ Askenazi","year":"2006","unstructured":"Askenazi DJ, Feig DI, Graham NM, Huo-Stickle S, Goldstein SL. 3\u20135 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int. 2006;69:184\u20139.","journal-title":"Kidney Int"},{"key":"1537_CR33","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/ki.2011.42","volume":"79","author":"LS Chawla","year":"2011","unstructured":"Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int. 2011;79:1361\u20139.","journal-title":"Kidney Int"},{"key":"1537_CR34","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/ndt\/gfn398","volume":"23","author":"B Ponte","year":"2008","unstructured":"Ponte B, Felipe C, Muriel A, Tenorio MT, Liano F. Long-term functional evolution after an acute kidney injury: a 10-year study. Nephrol Dial Transpl. 2008;23:3859\u201366.","journal-title":"Nephrol Dial Transpl"},{"key":"1537_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12882-017-0443-7","volume":"18","author":"S Surana","year":"2017","unstructured":"Surana S, Kumar N, Vasudeva A, Shaikh G, Jhaveri KD, Shah H, Malieckal D, Fogel J, Sidhu G, Rubinstein S. Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD. BMC Nephrol. 2017;18:26.","journal-title":"BMC Nephrol"},{"key":"1537_CR36","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1542\/peds.2013-3531","volume":"134","author":"ML Rinke","year":"2014","unstructured":"Rinke ML, Bundy DG, Velasquez CA, Rao S, Zerhouni Y, Lobner K, Blanck JF, Miller MR. Interventions to reduce pediatric medication errors: a systematic review. Pediatrics. 2014;134:338\u201360.","journal-title":"Pediatrics"},{"key":"1537_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2046-4053-3-56","volume":"3","author":"TK Nuckols","year":"2014","unstructured":"Nuckols TK, Smith-Spangler C, Morton SC, Asch SM, Patel VM, Anderson LJ, Deichsel EL, Shekelle PG. The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis. Syst Rev. 2014;3:56.","journal-title":"Syst Rev"},{"key":"1537_CR38","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1001\/jama.286.22.2839","volume":"286","author":"GM Chertow","year":"2001","unstructured":"Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, Lee R, Mekala A, Song J, Komaroff AL, Bates DW. Guided medication dosing for inpatients with renal insufficiency. JAMA. 2001;286:2839\u201344.","journal-title":"JAMA"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1537-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1537-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1537-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T22:32:14Z","timestamp":1751322734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1537-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1537"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1537-7","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"15 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Kazumoto Iijima has received grants from Daiichi Sankyo Co. Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All of the researchers in this study complied with the Helsinki Declaration and the Ethical Guidelines for Epidemiological Studies issued by the Ministry of Health, Labour and Welfare of Japan. With regard to informed consent, explanatory documents were attached to each questionnaire, and the act of mailing back the questionnaires was regarded as an indication of the subjects\u2019 willingness to participate in the survey. We fully protected any personal information by not collecting the subjects\u2019 name, initials, or age. The data obtained were anonymized. Prior to implementation, the study received approval (H25-34) from the ethics committee of Tokyo Metropolitan Children\u2019s Medical Center, this study\u2019s sponsoring institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"With regard to informed consent, explanatory documents were attached to each questionnaire, and the act of mailing back the questionnaires was regarded as an indication of the subjects\u2019 willingness to participate in the survey.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}